These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 19616741)

  • 1. In reply to Dr. Lee.
    Fowler JF
    Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1332-3. PubMed ID: 19616741
    [No Abstract]   [Full Text] [Related]  

  • 2. The ethics of hypofractionation for prostate cancer.
    Lee WR
    Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):969-70. PubMed ID: 19251081
    [No Abstract]   [Full Text] [Related]  

  • 3. A soft answer turneth away wrath. Proverbs 15:1.
    Hall EJ
    Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1333-4. PubMed ID: 19616742
    [No Abstract]   [Full Text] [Related]  

  • 4. Fractionation in prostate cancer--is it time after all?
    Baumann M; Hölscher T; Denham J
    Radiother Oncol; 2010 Jul; 96(1):1-5. PubMed ID: 20566227
    [No Abstract]   [Full Text] [Related]  

  • 5. Consensus statement: guidelines for PSA following radiation therapy. American Society for Therapeutic Radiology and Oncology Consensus Panel.
    Int J Radiat Oncol Biol Phys; 1997 Mar; 37(5):1035-41. PubMed ID: 9169810
    [No Abstract]   [Full Text] [Related]  

  • 6. Altered fractionation in radiotherapy: from radiobiological rationale to therapeutic gain.
    Marcu LG
    Cancer Treat Rev; 2010 Dec; 36(8):606-14. PubMed ID: 20494524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of technological advances in radiation oncology: from whence comes the funding?
    Cox JD
    Int J Radiat Oncol Biol Phys; 2008 Sep; 72(1):11. PubMed ID: 18722260
    [No Abstract]   [Full Text] [Related]  

  • 8. In reply to Baer.
    Potters L
    Int J Radiat Oncol Biol Phys; 2013 Mar; 85(4):897. PubMed ID: 23452450
    [No Abstract]   [Full Text] [Related]  

  • 9. Intensity modulated radiation therapy (IMRT): a new promising technology in radiation oncology.
    Teh BS; Woo SY; Butler EB
    Oncologist; 1999; 4(6):433-42. PubMed ID: 10631687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose fractionation and biological optimization in carcinoma of the prostate.
    Perez CA
    Rays; 2004; 29(3):237-52. PubMed ID: 15603294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of overall treatment time in the outcome of radiotherapy of prostate cancer: an analysis of biochemical failure in 4839 men treated between 1987 and 1995.
    Thames HD; Kuban D; Levy LB; Horwitz EM; Kupelian P; Martinez A; Michalski J; Pisansky T; Sandler H; Shipley W; Zelefsky M; Zietman A
    Radiother Oncol; 2010 Jul; 96(1):6-12. PubMed ID: 20400191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [History of radiation oncology and present state].
    Inokuchi H; Hiraoka M
    Nihon Rinsho; 2016 May; 74 Suppl 3():494-8. PubMed ID: 27344781
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical assessment of outcome of prostate cancer (TCP, NTCP).
    Perez CA; Michalski J; Mansur D
    Rays; 2005; 30(2):109-20. PubMed ID: 16294903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Progress in radiotherapeutic approaches to anal, rectal, bronchial and prostatic cancers].
    Van Houtte P; Mecellem H
    Rev Med Brux; 1997 Sep; 18(4):213-7. PubMed ID: 9411645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secondary malignancies from prostate cancer radiation treatment: a risk analysis of the influence of target margins and fractionation patterns.
    Daşu A; Toma-Daşu I; Franzén L; Widmark A; Nilsson P
    Int J Radiat Oncol Biol Phys; 2011 Mar; 79(3):738-46. PubMed ID: 20472345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fractionation and late rectal toxicity.
    Brenner DJ
    Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1013-5. PubMed ID: 15519768
    [No Abstract]   [Full Text] [Related]  

  • 17. Stereotactic body radiation therapy salvage reirradiation of radiorecurrent prostatic carcinoma relapsed in the prostatic bed.
    Arcangeli S; Gambardella P; Agolli L; Monaco A; Dognini J; Regine G; Donato V
    Tumori; 2015 Apr; 101(2):e57-9. PubMed ID: 25721678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Why stop at using high-dose-rate brachytherapy as a boost for the prostate?
    Beitler J
    J Clin Oncol; 2000 Dec; 18(23):4003-4;author reply 4005. PubMed ID: 11099335
    [No Abstract]   [Full Text] [Related]  

  • 19. Radiogenomics: associations in all the wrong places?
    Parliament MB
    Lancet Oncol; 2012 Jan; 13(1):7-8. PubMed ID: 22169270
    [No Abstract]   [Full Text] [Related]  

  • 20. Don't squeeze hypofractionated schedules into too-short overall times.
    Fowler J; King CR
    Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):323-5. PubMed ID: 19735858
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.